A reformulated RLS-2201 is being produced at BioCina's sterile manufacturing facility in Perth, under conditions designed to ...

As the demand for biologics accelerates, biopharma companies are under pressure to expand sterile manufacturing capacity ...

The two companies intend to leverage their complementary expertise and technology to bring a novel long acting injectable and drug product manufacturing platform to market. SACRAMENTO, Calif., Aug. 12 ...

The MarketWatch News Department was not involved in the creation of this content. GREENVILLE, S.C. and SACRAMENTO, Calif., Jan. 6, 2026 /PRNewswire/ -- PAI Pharma ("PAI"), a portfolio company of ...

Dublin, Dec. 16, 2019 (GLOBE NEWSWIRE) -- The "Sterile Injectable Drug Product Manufacturing Market Overview and Outlook" report has been added to ResearchAndMarkets.com's offering. Current demand for ...

WuXi STA launched a high potency, fully-automated sterile injectable manufacturing line at its drug product site in Wuxi City, China. The new line has an annual capacity of 12 million units and meets ...

-Adds BFS platform technology to provide large-scale production capacity for sterile drug dosage forms, including injectables, ophthalmics and inhalation Amneal will install dedicated manufacturing ...

Afton Scientific, a CDMO, plans to shell out $200 million to expand its manufacturing plant in Charlottesville, Virginia, as part of a project that includes hiring 200 new workers. The company, which ...

WILMINGTON, DE & WHIPPANY, NJ — The Noramco Group has announced a $25 million investment to expand its Halo Pharma facility ...